Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.
about
Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicabilityThe role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differencesArthritis susceptibility and the gut microbiome.Occasional presence of herpes viruses in synovial fluid and blood from patients with rheumatoid arthritis and axial spondyloarthritis.The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patientsHistorical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis.An unusual presentation of a common infection.Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.Chronic active Epstein-Barr virus infection with cutaneous and sinus lymphoproliferation in a white female patient with 25 years' follow-up: an original case report.Epstein-Barr virus in peripheral blood is associated with response to rituximab therapy in rheumatoid arthritis patients.Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome.Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.Predictive factors of rituximab response in rheumatoid arthritis: results from a French university hospital.
P2860
Q26771652-45838650-A2A2-4256-B9E4-5A8A78801BBFQ26866256-C4D6F65C-53AA-452E-8E30-08F5747E974AQ33358523-8F3F982A-378F-4B21-84B5-8B328EB8D7A4Q36073554-BAF3919D-2653-48DA-A8AE-DF1F6859A418Q36245889-5ADB3D5A-C1DB-475A-BC15-058EAB505CC0Q37272142-B9FFE02B-7082-4DBE-8884-E029EC7B886BQ37998089-5E6F5B4B-289F-4827-AA36-4D2327629E45Q39397490-3DE224AA-516F-43AE-8AC6-FEDC72912FFBQ40430043-08BEE5D2-88F1-4BCB-B153-ED8AFF0BAE0AQ41120745-4BD9F1CB-0430-45C1-BCCA-5E33BD06DA46Q41159831-FC05ACD1-C19C-4B70-8F92-6C9B3C53C916Q42214478-3185D7C7-A891-4137-A3EC-F14557B1DF6BQ42284576-73A5772C-B727-4BBB-82DB-6F07045DC08DQ43438627-F3F28ECD-CADF-437F-BFBD-F2BA8B9C46EE
P2860
Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@ast
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@en
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@nl
type
label
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@ast
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@en
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@nl
prefLabel
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@ast
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@en
Epstein-Barr virus in bone mar ...... sponse to rituximab treatment.
@nl
P2093
P2860
P356
P1433
P1476
Epstein-Barr virus in bone mar ...... esponse to rituximab treatment
@en
P2093
Kiandoht Zendjanchi
Magnus Lindh
Maria I Bokarewa
Mikael Brisslert
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ159
P577
2010-06-14T00:00:00Z